RareResearch.AI
← Back to atlas

K836N

Category 3/4 — Most DruggableLikely pathogenicLumenal · predictedσ-1 candidateEditorial
LysineAsparagine at position 836 · C-terminal lumenal domain (653-869) · WFS1 (Wolframin)

Lysine-to-asparagine substitution in a tryptophan-rich lumenal stretch — a positive charge is removed from a position flanked by two tryptophans (W837 covalent neighbor, W678 in through-space contact), suggesting a cation-pi anchor is being broken.

Interactive 3D Structure

Wild-type reference
Wild-type K836 — hydrophobic to W678
Fullscreen ↗
DynaMut2 mutant · K836N
Mutant N836 — hydrophobic contact to W678 lost
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

0 lost0 gained1 preserved
Interaction typeWild-type partnerMutant partnerStatus
HydrophobicW678W678Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-0.64kcal/mol
Destabilising — mild
AlphaMissense
0.996
LPath
AlphaFold pLDDT
82
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationLikely pathogenic
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsRare genetic deafness; Wolfram-like syndrome; Autosomal dominant nonsyndromic hearing loss 6
InheritanceWolfram-like syndrome and AD hearing loss 6 documented.
Population frequency (gnomAD v4)Absent from gnomAD v4
cDNA changec.2508G>C
ClinVar accessionVCV000228313
Last evaluated2025/06/11 00:00

Not observed in ~730k individuals — consistent with a rare allele (ACMG PM2_supporting).

Structural Context

K836 has a minimal contact set — only four neighbors within 5 Angstrom: Trp837 (2.45 Angstrom), Ser835 (2.49 Angstrom), Trp678 (3.37 Angstrom), and Pro838 (4.99 Angstrom). The two tryptophans are the structural feature that makes K836 mechanistically distinctive. Trp837 is the immediate covalent neighbor (the K-W sequence); Trp678 is far away in sequence but only 3.37 Angstrom away in space. Together they form a tryptophan pair that sandwiches the K836 lysine side chain.

The cation-pi interaction is well-documented: positively charged amines (lysine, arginine) and aromatic ring systems (tryptophan, phenylalanine, tyrosine) attract each other through favorable electrostatic interaction with the pi-electron cloud, contributing 2-5 kcal/mol per pair when the geometry is correct. With two tryptophans flanking K836, the lysine almost certainly engages in a cation-pi sandwich — a high-value structural anchor that holds the lumenal domain's local geometry together.

Replacing K836 with asparagine destroys this anchor twice over: the positive charge that drives the cation-pi interaction is gone, and the long aliphatic stem that placed the amine at the correct distance from both tryptophan rings is shortened by three carbons. Asparagine's amide can still form hydrogen bonds (likely with S835 and possibly with one of the tryptophan NH groups), but the cation-pi sandwich is structurally inaccessible.

DynaMut2 reports DeltaDeltaG = -0.64 kcal/mol — destabilising and mild on its face, but the energy function tends to under-read cation-pi losses because these interactions are quantum-mechanical in nature and not fully captured by classical force fields. AlphaMissense at 0.996 reads this position as extremely pathogenic — about as high a score as the model produces. The combination of high AM and modest DeltaDeltaG is the Atlas's clearest signature of a functional-site disruption that energy functions under-report.

Amino-acid chemistry
Lysine (large, positively charged, long aliphatic side chain ending in a primary amine) to Asparagine (neutral, short side chain ending in an amide) at position 836. The substitution removes both the charge and approximately three carbons of side-chain length.
Position in the protein
Position 836 sits inside the C-terminal lumenal domain (residues 653-869), the large soluble ATF6-interacting module. pLDDT 81.75 places K836 in an ordered, well-modeled region.

Druggability Assessment

Final classification: Category 3 — Most Druggable. The combination of high pLDDT (81.75), mild DeltaDeltaG (0.64 kcal/mol), and extreme AlphaMissense (0.996) is the classic Atlas signature of a high-value site-directed therapeutic target. The mechanism — cation-pi anchor disruption between K836 and the W837-W678 tryptophan pair — is structurally specific and small-molecule-tractable. The drug design target is the tryptophan pair itself: an aromatic compound that engages the W837-W678 stack and presents a positively charged feature (a guanidinium, a piperidinium, or a similar cation mimic) in the position the wild-type K836 would have occupied. This is exactly the kind of pharmacophore that small-molecule chemistry handles well. K836N is therefore a strong candidate for site-directed docking and chaperone screening.

Why this matters

K836N belongs to the small but important class of variants where the energy function under-reads severity because the disrupted interaction (cation-pi) is not well-captured. The Atlas's dual-metric framing (DeltaDeltaG plus AM) catches it; a stability-only triage would miss it. For the wolframin program, K836N is also a clinically distinct case — autosomal dominant hearing loss 6 is one of the most clinically penetrant phenotypes in the WFS1 spectrum, and a small-molecule rescue strategy that addresses K836N specifically could have an unusually clear translational path. The tryptophan-pair geometry is a defined, modelable site, and the AlphaMissense score (0.996) makes the case for therapeutic investment as strong as any variant in this batch.
Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the K836N PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download K836N PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.

UniProt Domain Annotation

Chain1890 · Wolframin
Topological domain653869 · Lumenal
Natural variant836836 · in WFSL; dbSNP:rs876657675